Fixed-dose combination chemotherapy versus multiple, single-drug chemotherapy for tuberculosis

Current Therapeutic Research - Clinical and Experimental

Volumn 57, Issue 11, 1996, Pages 849-856

  Zhang, Li Xing ^a   Kan, Guan Qing ^a   Tu, Do Hua ^a   Wan, Li Ya ^a   Faruqi, Abdul Rab ^b  

^a Beijing Res Inst for TB Control   (China)

^b Hoechst Marion Roussel   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; ISONIAZID PLUS RIFAMPICIN; PYRAZINAMIDE; RIFAMPICIN; RIFATER; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIOLOGY; CHEMOTHERAPY; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MIXTURE; DRUG PREFERENCE; DRUG SAFETY; FEMALE; HUMAN; LIVER DYSFUNCTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPUTUM CULTURE; TABLET; THROMBOCYTOPENIA;

EID: 0029944895     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(96)80018-X     Document Type: Article

References (10)

1. World Health Organization. First Programme Report (1991-1995) and Future Plan (1991-1995). WHO/TB/91.159. Geneva: World Health Organization; 1991.
2. Snider DE. Tuberculosis: The world situation. History of the disease and efforts to combat it. In: Porter JDH, McAdam KPWJ, eds. Tuberculosis: Back to the Future. Chichester, England: John Wiley & Sons Ltd; 1994:13-31.
3. World Health Organization. WHO quality assurance of anti-tuberculosis drugs, treatment of tuberculosis guidelines for national programmes. Geneva: World Health Organization; 1993:27.
4. Faruqi AR. The situation and prospectiveness of tuberculosis control in the world. Bull Chinese Anti-tuberculosis Assoc. 1992;14:95-96.
5. Weil DEC. Tuberculosis: Drug supply: Meeting a global need. In: Porter JDH, McAdam KPWJ, eds. Tuberculosis: Back to the Future. Chichester, England: John Wiley & Sons Ltd; 1994:123-149.
6. The promise and reality of fixed-dose combinations with rifampicin. A joint statement of the International Union Against Tuberculosis and Lung Disease and the Tuberculosis Programme of the World Health Organization. Tubercle Lung Dis. 1994;75:180-181.
7. Recommendations from the Committee on Treatment of International Union Against Tuberculosis and Lung Disease, anti-tuberculosis regimens of chemotherapy. Bull Int Union Tuberc Lung Dis. 1988;63:60.
8. World Health Organization. Guidelines for Tuberculosis Treatment in Adults and Children in National Tuberculosis Programmes. WHO/TB/91.161. Geneva: World Health Organization; 1991.
9. Zhang LX, Kan GQ. Tuberculosis control programme in Beijing. Tubercle Lung Dis. 1992;73:162-166.
10. Zhang LX, Kan GQ, Tu DH, et al. Trend of initial drug resistance of tubercle bacilli isolated from new patients with pulmonary tuberculosis and its correlation with the tuberculosis programme in Beijing. Tubercle Lung Dis. 1995;76:100-103.